Eva Maria Galan-Moya (Eva María Galán-Moya, Eva M Galan-Moya, Eva M Galán-Moya)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

Cancers

International journal of molecular sciences

Nutrients

Journal of experimental & clinical cancer research : CR

Universidad de Castilla-La Mancha

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Castilla-La Mancha Dec 01 2015

Spain

Investigador Acceso al Sistema Español de Ciencia, Tecnología e Innovación :: Ciencias Médicas

Publications

María Del Mar Noblejas-López, David Tébar-García, Raquel López-Rosa, Ana Alcaraz-Sanabria, Pablo Cristóbal-Cueto, Alejandro Pinedo-Serrano, Lorenzo Rivas-Garcia, Eva Maria Galan-Moya
TACkling Cancer by Targeting Selective Protein Degradation. Pharmaceutics 15 (10) (2023)
Miguel Burgos, Iván Cavero-Redondo, Celia Álvarez-Bueno, Eva Maria Galan-Moya, Atanasio Pandiella, Eitan Amir, Alberto Ocaña
Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis. Therapeutic advances in medical oncology 14 (2022)
María Del Mar Noblejas-López, Lucía Gandullo-Sánchez, Eva Maria Galan-Moya, Raquel López-Rosa, David Tébar-García, Cristina Nieto-Jiménez, Mónica Gómez-Juárez, Miguel Burgos, Atanasio Pandiella, Alberto Ocaña
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer. International journal of molecular sciences 23 (10) (2022)
Esther Cabañas Morafraile, Javier Pérez-Peña, Jesús Fuentes-Antrás, Aránzazu Manzano, Pedro Pérez-Segura, Atanasio Pandiella, Eva Maria Galan-Moya, Alberto Ocaña
Genomic Correlates of DNA Damage in Breast Cancer Subtypes. Cancers 13 (9) (2021)
Jesús Fuentes-Antrás, Ana Lucía Alcaraz-Sanabria, Esther Cabañas Morafraile, María Del Mar Noblejas-López, Eva Maria Galan-Moya, Mariona Baliu-Pique, Igor López-Cade, Vanesa García-Barberan, Pedro Pérez-Segura, Aránzazu Manzano, Atanasio Pandiella, Balázs Győrffy, Alberto Ocaña
Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery in Breast Cancer. Cancers 13 (4) (2021)
Lesgui Alviz, David Tebar-García, Raquel Lopez-Rosa, Eva Maria Galan-Moya, Natalia Moratalla-López, Gonzalo Luis Alonso, Eduardo Nava, Silvia Llorens
Pathogenic Microenvironment from Diabetic-Obese Visceral and Subcutaneous Adipocytes Activating Differentiation of Human Healthy Preadipocytes Increases Intracellular Fat, Effect of the Apocarotenoid Crocetin. Nutrients 13 (3) (2021)
Juan Luis Santiago, Jose Ramon Muñoz-Rodriguez, Miguel Angel de la Cruz-Morcillo, Clara Villar-Rodriguez, Lucia Gonzalez-Lopez, Carolina Aguado, Miriam Nuncia-Cantarero, Francisco Javier Redondo, Jose Manuel Perez-Ortiz, Eva Maria Galan-Moya
Characterization of Permeability Barrier Dysfunction in a Murine Model of Cutaneous Field Cancerization Following Chronic UV-B Irradiation: Implications for the Pathogenesis of Skin Cancer. Cancers 13 (16) (2021)
Leticia Serrano-Oviedo, Miriam Nuncia-Cantarero, Sara Morcillo-Garcia, Cristina Nieto-Jimenez, Miguel Burgos, Veronica Corrales-Sanchez, Javier Perez-Peña, Balázs Győrffy, Alberto Ocaña, Eva Maria Galan-Moya
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer. Cellular oncology (Dordrecht) 43 (3) (2020)
Verónica Corrales-Sánchez, María Del Mar Noblejas-López, Cristina Nieto-Jiménez, Javier Pérez-Peña, Juan Carlos Montero, Miguel Burgos, Eva Maria Galan-Moya, Atanasio Pandiella, Alberto Ocaña
Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer. Journal of cellular and molecular medicine 24 (5) (2020)
Jose Manuel Perez-Ortiz, Eva Maria Galan-Moya, Miguel Angel de la Cruz-Morcillo, Juan Francisco Rodriguez Romero, Ignacio Gracia, María Teresa García, Francisco Javier Redondo-Calvo
Cost Effective Use of a Thiosulfinate-Enriched Allium sativum Extract in Combination with Chemotherapy in Colon Cancer. International journal of molecular sciences 21 (8) (2020)
Cristina Nieto-Jimenez, Ana Alcaraz-Sanabria, Sandra Martinez-Canales, Veronica Corrales-Sanchez, Juan Carlos Montero, Miguel Burgos, Miriam Nuncia-Cantarero, Atanasio Pandiella, Eva Maria Galan-Moya, Alberto Ocaña
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer. International journal of molecular sciences 21 (23) (2020)
Sara Morcillo-Garcia, Maria Del Mar Noblejas-Lopez, Cristina Nieto-Jimenez, Javier Perez-Peña, Miriam Nuncia-Cantarero, Balázs Győrffy, Eitan Amir, Atanasio Pandiella, Eva Maria Galan-Moya, Alberto Ocaña
Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors. PloS one 14 (4) (2019)
María Del Mar Noblejas-López, Cristina Nieto-Jimenez, Miguel Burgos, Mónica Gómez-Juárez, Juan Carlos Montero, Azucena Esparís-Ogando, Atanasio Pandiella, Eva Maria Galan-Moya, Alberto Ocaña
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer. Journal of experimental & clinical cancer research : CR 38 (1) (2019)
Miriam Nuncia-Cantarero, Sandra Martinez-Canales, Fernando Andrés-Pretel, Gabriel Santpere, Alberto Ocaña, Eva Maria Galan-Moya
Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer. Breast cancer research and treatment 168 (3) (2018)
Sandra Martínez-Canales, Miguel López de Rodas, Miriam Nuncia-Cantarero, Raquel Páez, Eitan Amir, Balázs Győrffy, Atanasio Pandiella, Eva Maria Galan-Moya, Alberto Ocaña
Functional transcriptomic annotation and protein-protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer. Cancer medicine 7 (5) (2018)

Eva Maria Galan-Moya.css-eqlu8i{font-size:small;padding-left:4px;} (Eva María Galán-Moya, Eva M Galan-Moya, Eva M Galán-Moya)

Publication Activity (10 Years)

Top Topics

Top Venues

Eva Maria Galan-Moya (Eva María Galán-Moya, Eva M Galan-Moya, Eva M Galán-Moya)